Biocatalysis technology provides new way to produce active
cosmetic, nutritional and therapeutic moleculesToulouse, France, April 12, 2007 — LibraGen, specialist in the discovery and production of molecules for the healthcare, fine chemicals and cosmetics industry, announces today the availability of its first family of unique active products obtained through a patented enzymatic process.
The launch of this new range marks a significant step forward for LibraGen as an industry player in its own right for the design and production by biocatalysis of innovative high value-added molecules.
Using its proprietary technology platform, LibraGen has designed an exclusive enzymatic production process to allow the use of naturally derived active molecules which have hitherto proved difficult to exploit because of their physical and chemical properties. This first family of original products is aimed at the cosmetic manufacturers, pharmaceutical industry, and those in the nutrition sector.
This LibraGen's process transforms the raw materials into water-soluble active molecules. These are chemically more stable and have an improved biological availability thus opening up new opportunities to use the compounds for therapeutic, dermo-cosmetic and nutritional applications. This first series of compounds covers a wide and diverse range of biological structures and activities belonging to the polyphenols family.
"The market availability of this first collection of pioneering products is the result of LibraGen’s know-how in the development of new enzymatic reactions and the implementation of biocatalytic production processes," said Renaud Nalin, CEO at LibraGen. "This new range gives a glimpse of the potential we have with our technology and production capabilities as they are all applicable to other active ingredients. Some of our biosynthesized products have already been marketed on a large scale by our customers, and other dedicated product ranges are being produced for marketing in the future by major players in the field of natural products.
About LibraGen
LibraGen, Toulouse, France, specializes in the development of bioprocesses for the production of healthcare molecules and the discovery of new chemical scaffolds with cross-industry applications. By focusing on untapped biodiversity, the company has developed a platform of proven proprietary technologies to identify, validate and produce high added-value enzymes and molecules for industrial, pharmaceutical, chemical, cosmetic and environmental applications. The overall combination of LibraGen’s scientific and production know-how, technology platform and research results has already achieved a number of successful partnerships in research and production in the fields of cosmetics, pharmaceuticals and fine chemistry. In parallel with these partnerships with leading pharma companies, LibraGen’s internal research is building up a pipeline of new active molecules with anti-infectious and anti-cancer applications. For more information, visit www.libragen.com
Source: LibraGen
